{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:39:24Z","timestamp":1791257964762,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.3816\/clm.2006.n.029","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:17Z","timestamp":1221095417000},"page":"478-483","source":"Crossref","is-referenced-by-count":37,"title":["CD52 Is Expressed on Human Mast Cells and Is a Potential Therapeutic Target in Waldenstr\u00f6m's Macroglobulinemia and Mast Cell Disorders"],"prefix":"10.3816","volume":"6","author":[{"given":"Daniel Ditzel","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdoxia","family":"Hatjiharissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tournilhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Z.A.","family":"Chemaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Leleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Branagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen W.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary R.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Dimmock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery L.","family":"Kutok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winthrop H.","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tzu","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Treon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2006.n.029_bib1","first-page":"917a","article-title":"B-lymphocyte stimulator protein (BLYS) is expressed by bone marrow mast and lymphoplasmacytic cells in Waldenstrom's macroglobulinemia, and provides signaling for growth, survival and IgM secretion","volume":"104","author":"Ditzel Santos","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.029_bib2","doi-asserted-by":"crossref","first-page":"314b","DOI":"10.1182\/blood.V104.11.4929.4929","article-title":"Lymphoplasmacytic cells and mast cells are targets for imatinib mesylate in Waldenstrom's macroglobulinemia","volume":"104","author":"Tournilhac","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.029_bib3","doi-asserted-by":"crossref","first-page":"305b","DOI":"10.1182\/blood.V104.11.4892.4892","article-title":"Vascular endothelial growth factor is a growth and survival factor in Waldenstrom's macroglobulinemia","volume":"104","author":"Tournilhac","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.029_bib4","doi-asserted-by":"crossref","first-page":"856","DOI":"10.7326\/0003-4819-64-4-856","article-title":"The relation of mastocytosis and lymphomatous disease","volume":"64","author":"Nixon","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.3816\/CLM.2006.n.029_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia","volume":"30","author":"Pangalis","year":"2003","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2006.n.029_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/asheducation-2004.1.257","article-title":"Amyloidosis and Waldenstrom's macroglobulinemia","author":"Gertz","year":"2004","journal-title":"Hematology"},{"key":"10.3816\/CLM.2006.n.029_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/sonc.2003.50047","article-title":"Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations","volume":"30","author":"Treon","year":"2003","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2006.n.029_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3816\/CLM.2005.n.016","article-title":"CD52 expression in Waldenstrom's macroglobulinemia: implications for alemtuzumab therapy and response assessment","volume":"5","author":"Owen","year":"2005","journal-title":"Clin Lymphoma"},{"key":"10.3816\/CLM.2006.n.029_bib9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1309\/3G1XDX0DVHBNVKB4","article-title":"Immunophenotypic profile of lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia","volume":"124","author":"Konoplev","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2006.n.029_bib10","doi-asserted-by":"crossref","first-page":"313b","DOI":"10.1182\/blood.V104.11.4924.4924","article-title":"Campath-1H in Waldenstr\u00f6m's macroglobulinemia","volume":"104","author":"Hunter","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.029_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000203773","article-title":"Waldenstrom's macroglobulinemia associated with hyperplasia of the tissue mast cells","volume":"4","author":"Tischendorf","year":"1950","journal-title":"Acta Haematol"},{"key":"10.3816\/CLM.2006.n.029_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000205464","article-title":"Macroglobulinemia","volume":"20","author":"Waldenstrom","year":"1958","journal-title":"Acta Haematol"},{"key":"10.3816\/CLM.2006.n.029_bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1365-2559.2001.01173.x","article-title":"Tryptase-positive mast cells accompany lymphocytic as well as lymphoplasmacytic lymphoma infiltrates in bone marrow trephine biopsies","volume":"39","author":"Wilkins","year":"2001","journal-title":"Histopathology"},{"key":"10.3816\/CLM.2006.n.029_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/sonc.2003.50074","article-title":"Immunophenotypic analysis of Waldenstrom's macroglobulinemia","volume":"30","author":"San Miguel","year":"2003","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2006.n.029_bib15","doi-asserted-by":"crossref","first-page":"288a","DOI":"10.1182\/blood.V106.11.980.980","article-title":"Bone marrow mast cells are significantly increased in patients with Waldenstrom's macroglobulinemia, and their number following therapeutic intervention is dependent on extent of response","volume":"106","author":"Santos","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.029_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdl109","article-title":"Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154\/CD40 signaling","author":"Tournilhac","year":"2006","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2006.n.029_bib17","doi-asserted-by":"crossref","first-page":"255b","DOI":"10.1182\/blood.V106.11.4701.4701","article-title":"A novel functional role for soluble CD27 in the pathogenesis of Waldenstrom's macroglobulinemia","volume":"106","author":"Ho","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.029_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ajcp\/75.1.34","article-title":"Increased bone marrow mast cells in preleukemic syndromes, acute leukemia and lymphoproliferative disorders","volume":"75","author":"Prokocimer","year":"1981","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2006.n.029_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2141.2001.02977.x","article-title":"Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease","volume":"114","author":"Molin","year":"2001","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2006.n.029_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2141.2002.03768.x","article-title":"Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma","volume":"119","author":"Molin","year":"2002","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2006.n.029_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.it.2004.02.013","article-title":"Mast cells: the Jekyll and Hyde of tumor growth","volume":"25","author":"Theoharides","year":"2004","journal-title":"Trends Immunol"},{"key":"10.3816\/CLM.2006.n.029_bib22","first-page":"291","article-title":"Mastocytosis (mast cell disease). World Health Organization (WHO) classification of tumours. Pathology and genetics","volume":"Vol 1","author":"Valent","year":"2001"},{"key":"10.3816\/CLM.2006.n.029_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2004.02.045","article-title":"Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and nonmast cell hematopoietic neoplasms","volume":"114","author":"Valent","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.3816\/CLM.2006.n.029_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Butterfield","year":"1988","journal-title":"Leuk Res"},{"key":"10.3816\/CLM.2006.n.029_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0145-2126(02)00343-0","article-title":"Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma\/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI [published erratum in Leuk Res 2003; 27:1171]","volume":"27","author":"Kirshenbaum","year":"2003","journal-title":"Leuk Res"},{"key":"10.3816\/CLM.2006.n.029_bib26","doi-asserted-by":"crossref","unstructured":"Hunter ZR, Branagan AR, Santos DD, et al. High levels of soluble immunoregulatory receptors in patients with Waldenstrom's macroglobulinemia. Blood 104:303b (Abstract #4881).","DOI":"10.1182\/blood.V104.11.4881.4881"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T06:09:25Z","timestamp":1588918165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011702852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S1557919011702852"],"URL":"https:\/\/doi.org\/10.3816\/clm.2006.n.029","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}